Global Veterinary Anesthesia Drug Market Growth 2024-2030

Publication ID:

LPI08246851

Publication Date:

August 22, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Veterinary Anesthesia Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淰eterinary Anesthesia Drug Industry Forecast鈥� looks at past sales and reviews total world Veterinary Anesthesia Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Veterinary Anesthesia Drug sales for 2024 through 2030. With Veterinary Anesthesia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Anesthesia Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Anesthesia Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Anesthesia Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Veterinary Anesthesia Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Anesthesia Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Anesthesia Drug.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Anesthesia Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Ketamine
Propofol
Thiopental
Others
Segmentation by application
Pet
Agricultural Livestock
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dechra
LGC Group
AuroMedics
Evonik
Gedeon Richter
Midas Pharma
Fresenius Kabi AG
AstraZeneca
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Anesthesia Drug market?
What factors are driving Veterinary Anesthesia Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Anesthesia Drug market opportunities vary by end market size?
How does Veterinary Anesthesia Drug break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Anesthesia Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Veterinary Anesthesia Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Veterinary Anesthesia Drug by Country/Region, 2019, 2023 & 2030
2.2 Veterinary Anesthesia Drug Segment by Type
2.2.1 Ketamine
2.2.2 Propofol
2.2.3 Thiopental
2.2.4 Others
2.3 Veterinary Anesthesia Drug Sales by Type
2.3.1 Global Veterinary Anesthesia Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Veterinary Anesthesia Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Veterinary Anesthesia Drug Sale Price by Type (2019-2024)
2.4 Veterinary Anesthesia Drug Segment by Application
2.4.1 Pet
2.4.2 Agricultural Livestock
2.4.3 Others
2.5 Veterinary Anesthesia Drug Sales by Application
2.5.1 Global Veterinary Anesthesia Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Veterinary Anesthesia Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Veterinary Anesthesia Drug Sale Price by Application (2019-2024)
3 Global Veterinary Anesthesia Drug by Company
3.1 Global Veterinary Anesthesia Drug Breakdown Data by Company
3.1.1 Global Veterinary Anesthesia Drug Annual Sales by Company (2019-2024)
3.1.2 Global Veterinary Anesthesia Drug Sales Market Share by Company (2019-2024)
3.2 Global Veterinary Anesthesia Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Veterinary Anesthesia Drug Revenue by Company (2019-2024)
3.2.2 Global Veterinary Anesthesia Drug Revenue Market Share by Company (2019-2024)
3.3 Global Veterinary Anesthesia Drug Sale Price by Company
3.4 Key Manufacturers Veterinary Anesthesia Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Anesthesia Drug Product Location Distribution
3.4.2 Players Veterinary Anesthesia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Anesthesia Drug by Geographic Region
4.1 World Historic Veterinary Anesthesia Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Veterinary Anesthesia Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Veterinary Anesthesia Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Veterinary Anesthesia Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Veterinary Anesthesia Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Veterinary Anesthesia Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Veterinary Anesthesia Drug Sales Growth
4.4 APAC Veterinary Anesthesia Drug Sales Growth
4.5 Europe Veterinary Anesthesia Drug Sales Growth
4.6 Middle East & Africa Veterinary Anesthesia Drug Sales Growth
5 Americas
5.1 Americas Veterinary Anesthesia Drug Sales by Country
5.1.1 Americas Veterinary Anesthesia Drug Sales by Country (2019-2024)
5.1.2 Americas Veterinary Anesthesia Drug Revenue by Country (2019-2024)
5.2 Americas Veterinary Anesthesia Drug Sales by Type
5.3 Americas Veterinary Anesthesia Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Anesthesia Drug Sales by Region
6.1.1 APAC Veterinary Anesthesia Drug Sales by Region (2019-2024)
6.1.2 APAC Veterinary Anesthesia Drug Revenue by Region (2019-2024)
6.2 APAC Veterinary Anesthesia Drug Sales by Type
6.3 APAC Veterinary Anesthesia Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Anesthesia Drug by Country
7.1.1 Europe Veterinary Anesthesia Drug Sales by Country (2019-2024)
7.1.2 Europe Veterinary Anesthesia Drug Revenue by Country (2019-2024)
7.2 Europe Veterinary Anesthesia Drug Sales by Type
7.3 Europe Veterinary Anesthesia Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Anesthesia Drug by Country
8.1.1 Middle East & Africa Veterinary Anesthesia Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Veterinary Anesthesia Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Veterinary Anesthesia Drug Sales by Type
8.3 Middle East & Africa Veterinary Anesthesia Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Anesthesia Drug
10.3 Manufacturing Process Analysis of Veterinary Anesthesia Drug
10.4 Industry Chain Structure of Veterinary Anesthesia Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Anesthesia Drug Distributors
11.3 Veterinary Anesthesia Drug Customer
12 World Forecast Review for Veterinary Anesthesia Drug by Geographic Region
12.1 Global Veterinary Anesthesia Drug Market Size Forecast by Region
12.1.1 Global Veterinary Anesthesia Drug Forecast by Region (2025-2030)
12.1.2 Global Veterinary Anesthesia Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Anesthesia Drug Forecast by Type
12.7 Global Veterinary Anesthesia Drug Forecast by Application
13 Key Players Analysis
13.1 Dechra
13.1.1 Dechra Company Information
13.1.2 Dechra Veterinary Anesthesia Drug Product Portfolios and Specifications
13.1.3 Dechra Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Dechra Main Business Overview
13.1.5 Dechra Latest Developments
13.2 LGC Group
13.2.1 LGC Group Company Information
13.2.2 LGC Group Veterinary Anesthesia Drug Product Portfolios and Specifications
13.2.3 LGC Group Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 LGC Group Main Business Overview
13.2.5 LGC Group Latest Developments
13.3 AuroMedics
13.3.1 AuroMedics Company Information
13.3.2 AuroMedics Veterinary Anesthesia Drug Product Portfolios and Specifications
13.3.3 AuroMedics Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AuroMedics Main Business Overview
13.3.5 AuroMedics Latest Developments
13.4 Evonik
13.4.1 Evonik Company Information
13.4.2 Evonik Veterinary Anesthesia Drug Product Portfolios and Specifications
13.4.3 Evonik Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Evonik Main Business Overview
13.4.5 Evonik Latest Developments
13.5 Gedeon Richter
13.5.1 Gedeon Richter Company Information
13.5.2 Gedeon Richter Veterinary Anesthesia Drug Product Portfolios and Specifications
13.5.3 Gedeon Richter Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Gedeon Richter Main Business Overview
13.5.5 Gedeon Richter Latest Developments
13.6 Midas Pharma
13.6.1 Midas Pharma Company Information
13.6.2 Midas Pharma Veterinary Anesthesia Drug Product Portfolios and Specifications
13.6.3 Midas Pharma Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Midas Pharma Main Business Overview
13.6.5 Midas Pharma Latest Developments
13.7 Fresenius Kabi AG
13.7.1 Fresenius Kabi AG Company Information
13.7.2 Fresenius Kabi AG Veterinary Anesthesia Drug Product Portfolios and Specifications
13.7.3 Fresenius Kabi AG Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fresenius Kabi AG Main Business Overview
13.7.5 Fresenius Kabi AG Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Veterinary Anesthesia Drug Product Portfolios and Specifications
13.8.3 AstraZeneca Veterinary Anesthesia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂